Analysis and Commentary STEVEN GROSSMAN 10/7/11 Analysis and Commentary STEVEN GROSSMAN 10/7/11 Innovation in Passing ... And For the Future Read More Analysis and Commentary STEVEN GROSSMAN 9/30/11 Analysis and Commentary STEVEN GROSSMAN 9/30/11 Could FDA See More Than a $50 Million Increase for FY 12? Read More Analysis and Commentary STEVEN GROSSMAN 9/16/11 Analysis and Commentary STEVEN GROSSMAN 9/16/11 House, Senate Get High Marks for Commitment Read More Analysis and Commentary STEVEN GROSSMAN 9/9/11 Analysis and Commentary STEVEN GROSSMAN 9/9/11 FDA Funding Confronts the "New Normal" Read More Analysis and Commentary STEVEN GROSSMAN 8/26/11 Analysis and Commentary STEVEN GROSSMAN 8/26/11 Quantum Politics and the Rogers-Inouye Certainty Principle Read More Analysis and Commentary STEVEN GROSSMAN 8/19/11 Analysis and Commentary STEVEN GROSSMAN 8/19/11 The FDA and the BCA -- A Compact Update Read More Analysis and Commentary STEVEN GROSSMAN 8/13/11 Analysis and Commentary STEVEN GROSSMAN 8/13/11 The Super Committee and Its Mission Read More Analysis and Commentary STEVEN GROSSMAN 8/5/11 Analysis and Commentary STEVEN GROSSMAN 8/5/11 After BCA ... What Are the Next Steps? Read More Analysis and Commentary STEVEN GROSSMAN 8/2/11 Analysis and Commentary STEVEN GROSSMAN 8/2/11 Preliminary Analysis of "Budget Control Act" Read More Analysis and Commentary STEVEN GROSSMAN 7/30/11 Analysis and Commentary STEVEN GROSSMAN 7/30/11 A Re-statement of Our Position on FY 12 Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 7/22/11 Analysis and Commentary STEVEN GROSSMAN 7/22/11 August 2 Is Only 10 or 11 Days Away Read More Analysis and Commentary STEVEN GROSSMAN 7/15/11 Analysis and Commentary STEVEN GROSSMAN 7/15/11 The Week That "Nothing" Happened Read More Analysis and Commentary STEVEN GROSSMAN 7/8/11 Analysis and Commentary STEVEN GROSSMAN 7/8/11 Re-thinking the House Position Read More Analysis and Commentary STEVEN GROSSMAN 6/30/11 Analysis and Commentary STEVEN GROSSMAN 6/30/11 Making the Case ... Senate Side Read More Analysis and Commentary STEVEN GROSSMAN 6/24/11 Analysis and Commentary STEVEN GROSSMAN 6/24/11 When Will the Senate Consider FDA Appropriations? Read More Analysis and Commentary STEVEN GROSSMAN 6/17/11 Analysis and Commentary STEVEN GROSSMAN 6/17/11 User Fees No Replacement for Public Funding Read More Analysis and Commentary STEVEN GROSSMAN 6/11/11 Analysis and Commentary STEVEN GROSSMAN 6/11/11 The FDA's Washington Monument Strategy Read More Analysis and Commentary STEVEN GROSSMAN 6/3/11 Analysis and Commentary STEVEN GROSSMAN 6/3/11 Some Fireworks ... But Mostly What Was Expected Read More Analysis and Commentary STEVEN GROSSMAN 5/27/11 Analysis and Commentary STEVEN GROSSMAN 5/27/11 A Time for Prompt, Serious, and Focused Action Read More Analysis and Commentary STEVEN GROSSMAN 5/20/11 Analysis and Commentary STEVEN GROSSMAN 5/20/11 A Gathering Storm ... Or Just a Little Bluster? Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 10/7/11 Analysis and Commentary STEVEN GROSSMAN 10/7/11 Innovation in Passing ... And For the Future Read More
Analysis and Commentary STEVEN GROSSMAN 9/30/11 Analysis and Commentary STEVEN GROSSMAN 9/30/11 Could FDA See More Than a $50 Million Increase for FY 12? Read More
Analysis and Commentary STEVEN GROSSMAN 9/16/11 Analysis and Commentary STEVEN GROSSMAN 9/16/11 House, Senate Get High Marks for Commitment Read More
Analysis and Commentary STEVEN GROSSMAN 9/9/11 Analysis and Commentary STEVEN GROSSMAN 9/9/11 FDA Funding Confronts the "New Normal" Read More
Analysis and Commentary STEVEN GROSSMAN 8/26/11 Analysis and Commentary STEVEN GROSSMAN 8/26/11 Quantum Politics and the Rogers-Inouye Certainty Principle Read More
Analysis and Commentary STEVEN GROSSMAN 8/19/11 Analysis and Commentary STEVEN GROSSMAN 8/19/11 The FDA and the BCA -- A Compact Update Read More
Analysis and Commentary STEVEN GROSSMAN 8/13/11 Analysis and Commentary STEVEN GROSSMAN 8/13/11 The Super Committee and Its Mission Read More
Analysis and Commentary STEVEN GROSSMAN 8/5/11 Analysis and Commentary STEVEN GROSSMAN 8/5/11 After BCA ... What Are the Next Steps? Read More
Analysis and Commentary STEVEN GROSSMAN 8/2/11 Analysis and Commentary STEVEN GROSSMAN 8/2/11 Preliminary Analysis of "Budget Control Act" Read More
Analysis and Commentary STEVEN GROSSMAN 7/30/11 Analysis and Commentary STEVEN GROSSMAN 7/30/11 A Re-statement of Our Position on FY 12 Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 7/22/11 Analysis and Commentary STEVEN GROSSMAN 7/22/11 August 2 Is Only 10 or 11 Days Away Read More
Analysis and Commentary STEVEN GROSSMAN 7/15/11 Analysis and Commentary STEVEN GROSSMAN 7/15/11 The Week That "Nothing" Happened Read More
Analysis and Commentary STEVEN GROSSMAN 7/8/11 Analysis and Commentary STEVEN GROSSMAN 7/8/11 Re-thinking the House Position Read More
Analysis and Commentary STEVEN GROSSMAN 6/30/11 Analysis and Commentary STEVEN GROSSMAN 6/30/11 Making the Case ... Senate Side Read More
Analysis and Commentary STEVEN GROSSMAN 6/24/11 Analysis and Commentary STEVEN GROSSMAN 6/24/11 When Will the Senate Consider FDA Appropriations? Read More
Analysis and Commentary STEVEN GROSSMAN 6/17/11 Analysis and Commentary STEVEN GROSSMAN 6/17/11 User Fees No Replacement for Public Funding Read More
Analysis and Commentary STEVEN GROSSMAN 6/11/11 Analysis and Commentary STEVEN GROSSMAN 6/11/11 The FDA's Washington Monument Strategy Read More
Analysis and Commentary STEVEN GROSSMAN 6/3/11 Analysis and Commentary STEVEN GROSSMAN 6/3/11 Some Fireworks ... But Mostly What Was Expected Read More
Analysis and Commentary STEVEN GROSSMAN 5/27/11 Analysis and Commentary STEVEN GROSSMAN 5/27/11 A Time for Prompt, Serious, and Focused Action Read More
Analysis and Commentary STEVEN GROSSMAN 5/20/11 Analysis and Commentary STEVEN GROSSMAN 5/20/11 A Gathering Storm ... Or Just a Little Bluster? Read More
